The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome
- PMID: 20587693
- PMCID: PMC2970629
- DOI: 10.1177/0300985810374842
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome
Abstract
Vascular Ehlers-Danlos syndrome is a rare genetic disorder resulting from mutations in the α-1 chain of type III collagen (COL3A1) and manifesting as tissue fragility with spontaneous rupture of the bowel, gravid uterus, or large or medium arteries. The heterozygous Col3a1 knockout mouse was investigated as a model for this disease. The collagen content in the abdominal aorta of heterozygotes was reduced, and functional testing revealed diminishing wall strength of the aorta in these mice. Colons were grossly and histologically normal, but reduced strength and increased compliance of the wall were found in heterozygotes via pressure testing. Although mice demonstrated no life-threatening clinical signs or gross lesions of vascular subtype Ehlers-Danlos syndrome type IV, thorough histological examination of the aorta of heterozygous mice revealed the presence of a spectrum of lesions similar to those observed in human patients. Lesions increased in number and severity with age (0/5 [0%] in 2-month-old males vs 9/9 [100%] in 14-month-old males, P < .05) and were more common in male than female mice (23/26 [88.5%] vs 14/30 [46.7%] in 9- to 21-month-old animals, P < .05). Haploinsufficiency for Col3a1 in mice recapitulates features of vascular Ehlers-Danlos syndrome in humans and can be used as an experimental model.
Conflict of interest statement
The authors declared that they had no conflicts of interests with respect to their authorship or the publication of this article.
Figures

















References
-
- Barabas AP. Ehlers-Danlos syndrome type IV. N Engl J Med. 2000;343:366. author reply 368. - PubMed
-
- Baxter BT. Heritable diseases of the blood vessels. Cardiovasc Pathol. 2005;14:185–188. - PubMed
-
- Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK) Am J Med Genet. 1998;77:31–37. - PubMed
-
- Blaker H, Funke B, Hausser I, Hackert T, Schirmacher P, Autschbach F. Pathology of the large intestine in patients with vascular type Ehlers-Danlos syndrome. Virchows Arch. 2007;450:713–717. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous